Share on StockTwits

Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating restated by Goodbody Stockbrokers Ltd in a research note issued on Wednesday, Analyst Ratings News reports.

Several other analysts have also recently commented on the stock. Analysts at Investec raised their price target on shares of Udg Healthcare PLC from GBX 305 ($5.14) to GBX 360 ($6.06) in a research note on Wednesday. They now have a “hold” rating on the stock. Separately, analysts at N 1 Singer reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Wednesday. They now have a GBX 410 ($6.91) price target on the stock. Finally, analysts at N+1 Singer reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Wednesday. They now have a GBX 410 ($6.91) price target on the stock. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of GBX 386 ($6.50).

Udg Healthcare PLC (LON:UDG) opened at 367.00 on Wednesday. Udg Healthcare PLC has a 52 week low of GBX 293.30 and a 52 week high of GBX 380.10. The stock’s 50-day moving average is GBX 356.7 and its 200-day moving average is GBX 340.7. The company’s market cap is £885.6 million.

UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in over 20 countries including the United States, the United Kingdom, Ireland, Germany, the Netherlands and Belgium.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.